Clinicopathological correlates, oncological impact, and validation of Oncotype DX™ in a European Tertiary Referral Centre-Reference-Cited by-同舟云学术

Clinicopathological correlates, oncological impact, and validation of Oncotype DX™ in a European Tertiary Referral Centre

Published:2021-03-11 Issue:6 Volume:27 Page:521-528
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Davey Matthew G.¹²^ORCID,Ryan Éanna J.¹,Abd Elwahab Sami¹,Elliott Jessie A.¹,McAnena Peter F.¹,Sweeney Karl J.¹,Malone Carmel M.¹,McLaughlin Ray¹,Barry Michael K.¹,Keane Maccon M.³,Lowery Aoife J.¹²,Kerin Michael J.¹²

Affiliation:

1. Department of Surgery Galway University Hospitals Galway Ireland

2. The Lambe Institute for Translational ResearchNational University of Ireland Galway Ireland

3. Department of Medical Oncology Galway University Hospitals Galway Ireland

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.14217

Reference58 articles.

1. Global Patterns of Cancer Incidence and Mortality Rates and Trends

2. The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches

3. The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre

4. The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis

5. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNAs as biomarkers breast cancer and their influence on tumor epigenetics;Epigenetics in Human Disease;2024

2. Subspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff;Breast Cancer Research and Treatment;2023-12-29

3. Evaluating the Necessity for Routine Sentinel Lymph Node Biopsy in Postmenopausal Patients Being Treated for Clinically Node Negative Breast Cancer the Era of RxPONDER;Clinical Breast Cancer;2023-07

4. The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2− Breast Cancer;Advances in Therapy;2023-06-29

5. Evaluation oncotype DX^® 21‐gene recurrence score and clinicopathological parameters: a single institutional experience;Histopathology;2023-02